Remove 2010 Remove Clinical Trials Remove Collective Remove Concentrates
article thumbnail

Cannabinoids for Tinnitus?

Project CBD

Whatever the precise nature of the phantom sound, it often comes with a constellation of symptoms related to the disruption such a condition can bring: sleep problems, difficulty concentrating, low mood, etc. While the collective evidence to date is mixed and inconclusive, it’s also incomplete. 268,1-2 (2010): 145-50.

article thumbnail

Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers

Cannabis Law Report

Borrowing from what is already known about safe circulating levels in patients for generic cepharanthine, the Company’s current 60 cancer screen was designed to investigate the impact of their patented cepharanthine formulation at concentrations that are predicted to be safe to patients 1. ” Next Steps.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Data collection. However, from 2010, a dramatic increase is observable in articles about medicinal cannabis in the publications under analysis. It is important to note that the most concentrated periods for stories framing safety concerns about cannabis were in 2019 ( n ?=?7) Oxford: Wiley-Blackwell; 2010. Google Scholar.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45